Efficacy and Safety of Apatinib in Patients with Recurrent Glioblastoma

BACKGROUND AND OBJECTIVE: Glioblastoma is a cranial malignant tumor with a high recurrence rate after surgery and a poor response to chemoradiotherapy. Bevacizumab has demonstrated efficacy in the treatment of glioblastoma by inhibiting vascular endothelial growth factor, but the efficacy of vascula...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Hao, Zhou, Xinli, Sheng, Xiaofang, Liang, Xiaohua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2023
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10439071/
https://www.ncbi.nlm.nih.gov/pubmed/37466833
http://dx.doi.org/10.1007/s40268-023-00429-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10439071/
https://www.ncbi.nlm.nih.gov/pubmed/37466833
http://dx.doi.org/10.1007/s40268-023-00429-3

Ejemplares similares